v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Follow-On Offering
Common Stock
Common Stock
Follow-On Offering
Additional Paid-in Capital
Additional Paid-in Capital
Follow-On Offering
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning Balance at Dec. 31, 2023 $ 225,848       $ 512,617   $ (287,308) $ 539
Beginning Balance, Shares at Dec. 31, 2023     49,350,788          
Stock-based compensation expense 2,909       2,909      
Employee Stock Purchase Plan issuance 95       95      
Employee Stock Purchase Plan issuance, Shares     12,314          
Stock option exercises 158       158      
Stock option exercises, Shares     51,180          
Vesting of restricted stock, Shares     90,123          
Unrealized loss on marketable securities (521)             (521)
Net loss (19,706)           (19,706)  
Ending Balance at Mar. 31, 2024 208,783       515,779   (307,014) 18
Ending Balance, Shares at Mar. 31, 2024     49,504,405          
Beginning Balance at Dec. 31, 2023 225,848       512,617   (287,308) 539
Beginning Balance, Shares at Dec. 31, 2023     49,350,788          
Unrealized loss on marketable securities (722)              
Net loss (40,043)              
Ending Balance at Jun. 30, 2024 191,454       518,988   (327,351) (183)
Ending Balance, Shares at Jun. 30, 2024     49,583,358          
Beginning Balance at Mar. 31, 2024 208,783       515,779   (307,014) 18
Beginning Balance, Shares at Mar. 31, 2024     49,504,405          
Stock-based compensation expense 3,126       3,126      
Stock option exercises 83       83      
Stock option exercises, Shares     24,245          
Vesting of restricted stock, Shares     54,708          
Unrealized loss on marketable securities (201)             (201)
Net loss (20,337)           (20,337)  
Ending Balance at Jun. 30, 2024 191,454       518,988   (327,351) (183)
Ending Balance, Shares at Jun. 30, 2024     49,583,358          
Beginning Balance at Dec. 31, 2024 151,970       525,934   (374,227) 263
Beginning Balance, Shares at Dec. 31, 2024     49,998,279          
Stock-based compensation expense 3,514       3,514      
Employee Stock Purchase Plan issuance 96       96      
Employee Stock Purchase Plan issuance, Shares     15,263          
Vesting of restricted stock, Shares     211,770          
Unrealized loss on marketable securities (137)             (137)
Currency translation adjustment (21)             (21)
Other 27       27      
Net loss (27,483)           (27,483)  
Ending Balance at Mar. 31, 2025 127,966       529,571   (401,710) 105
Ending Balance, Shares at Mar. 31, 2025     50,225,312          
Beginning Balance at Dec. 31, 2024 151,970       525,934   (374,227) 263
Beginning Balance, Shares at Dec. 31, 2024     49,998,279          
Unrealized loss on marketable securities (226)              
Currency translation adjustment (12)              
Net loss (54,502)              
Ending Balance at Jun. 30, 2025 174,629       603,333   (428,729) 25
Ending Balance, Shares at Jun. 30, 2025     62,071,050          
Beginning Balance at Mar. 31, 2025 127,966       529,571   (401,710) 105
Beginning Balance, Shares at Mar. 31, 2025     50,225,312          
Stock-based compensation expense 3,833       3,833      
Stock option exercises 2       2      
Stock option exercises, Shares     1,424          
Vesting of restricted stock, Shares     108,749          
Issuance of common stock   $ 46,517       $ 46,517    
Issuance of common stock, Shares       11,735,565        
Issuance of pre-funded warrants   14,156       14,156    
Issuance of common stock warrants   $ 9,254       $ 9,254    
Unrealized loss on marketable securities (88)             (88)
Currency translation adjustment 8             8
Net loss (27,019)           (27,019)  
Ending Balance at Jun. 30, 2025 $ 174,629       $ 603,333   $ (428,729) $ 25
Ending Balance, Shares at Jun. 30, 2025     62,071,050